https://www.selleckchem.com/products/c-75.html
Differences in information between MPGP and the drug labeling were identified in 26 of 30 drug labeling analyzed, most often due to age (24/26) followed by indication (2/26). No differences pertaining to dosage or route of administration information were identified. The number of approved psychotropic medicines varied across the studied countries and we found cross-country discrepancies in information in the drug labeling. Conclusion Significant differences in information exists between MPGP and the drug labeling for psychotropic medicines
Like
Comment
Share
